| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |